129 related articles for article (PubMed ID: 9143570)
1. High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients.
Noun R; Jagot P; Farges O; Sauvanet A; Belghiti J
World J Surg; 1997 May; 21(4):390-4; discussion 395. PubMed ID: 9143570
[TBL] [Abstract][Full Text] [Related]
2. Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
Lai CY; Wu CC; Wang J; Yu CC; Cheng SB; Yeh DC; Peng FK
Hepatogastroenterology; 2014 Oct; 61(135):2068-76. PubMed ID: 25713912
[TBL] [Abstract][Full Text] [Related]
3. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
4. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?
Wu CC; Ho WL; Lin MC; Tang JS; Yeh DC; Liu TJ; P'eng FK
Hepatogastroenterology; 1999; 46(26):635-9. PubMed ID: 10370588
[TBL] [Abstract][Full Text] [Related]
5. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
[TBL] [Abstract][Full Text] [Related]
6. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.
Yang T; Zhang J; Lu JH; Yang GS; Wu MC; Yu WF
World J Surg; 2011 Sep; 35(9):2073-82. PubMed ID: 21656309
[TBL] [Abstract][Full Text] [Related]
7. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
[TBL] [Abstract][Full Text] [Related]
8. Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.
Tarao K; Rino Y; Takemiya S; Ohkawa S; Sugimasa Y; Miyakawa K; Tamai S; Masaki T; Hirokawa S; Kameda Y; Nagaoka T; Okamoto N; Kokubu S; Yoshida M; Kakita A
Cancer Sci; 2003 Dec; 94(12):1083-90. PubMed ID: 14662024
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.
Harada N; Shirabe K; Ikeda Y; Korenaga D; Takenaka K; Maehara Y
Ann Transplant; 2012 Dec; 17(4):11-20. PubMed ID: 23274319
[TBL] [Abstract][Full Text] [Related]
10. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.
Fan ST; Lai EC; Lo CM; Ng IO; Wong J
Arch Surg; 1995 Feb; 130(2):198-203. PubMed ID: 7848092
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
[TBL] [Abstract][Full Text] [Related]
12. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma.
Tarao K; Rino Y; Takemiya S; Tamai S; Ohkawa S; Sugimasa Y; Miyakawa K; Morinaga S; Yoshida M; Shibuya A; Kokubu S; Kakita A; Endo O
Intervirology; 2000; 43(1):20-6. PubMed ID: 10773734
[TBL] [Abstract][Full Text] [Related]
13. Postoperative day one serum alanine aminotransferase does not predict patient morbidity and mortality after elective liver resection in non-cirrhotic patients.
Bhogal RH; Nair A; Papis D; Hamady Z; Ahmad J; Lam FT; Khan S; Marangoni G
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):655-659. PubMed ID: 27919856
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcome in cirrhotic patients with hepatitis C-related hepatocellular carcinoma.
Hanazaki K; Wakabayashi M; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Kawamura N; Miyazaki T
Hepatogastroenterology; 2000; 47(31):204-10. PubMed ID: 10690610
[TBL] [Abstract][Full Text] [Related]
15. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.
Tarao K; Takemiya S; Tamai S; Sugimasa Y; Ohkawa S; Akaike M; Tanabe H; Shimizu A; Yoshida M; Kakita A
Cancer; 1997 Feb; 79(4):688-94. PubMed ID: 9024706
[TBL] [Abstract][Full Text] [Related]
17. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
[TBL] [Abstract][Full Text] [Related]
18. Characteristic risk factors in cirrhotic patients for posthepatectomy complications: comparison with noncirrhotic patients.
Itoh S; Uchiyama H; Kawanaka H; Higashi T; Egashira A; Eguchi D; Okuyama T; Tateishi M; Korenaga D; Takenaka K
Am Surg; 2014 Feb; 80(2):166-70. PubMed ID: 24480217
[TBL] [Abstract][Full Text] [Related]
19. Partial hepatectomy on cirrhotic liver with a right lateral tumor.
Lee CS; Chao CC; Lin TY
Surgery; 1985 Nov; 98(5):942-8. PubMed ID: 2997944
[TBL] [Abstract][Full Text] [Related]
20. Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma - A risk factor analysis.
Blüthner E; Jara M; Shrestha R; Faber W; Pratschke J; Stockmann M; Malinowski M
Surg Oncol; 2020 Jun; 33():257-265. PubMed ID: 32561090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
